Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis

Xueyan Chen1, Sindhu Cherian1

  • 1Department of Laboratory Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195, USA.

Insights

Flow cytometry is crucial for diagnosing acute myeloid leukemia (AML). This review covers immunophenotyping strategies, antibody panels, and markers for AML subclassification and minimal residual disease detection.

Area of Science:

  • Hematology
  • Immunology
  • Clinical Pathology

Background:

  • Flow cytometry is essential for acute myeloid leukemia (AML) diagnosis and subclassification.
  • Multiparametric flow cytometry offers efficient and highly sensitive immunophenotyping.
  • Accurate subclassification aids in treatment selection and prognosis.

Purpose of the Study:

  • To review the utility of flow cytometry in acute myeloid leukemia (AML).
  • To outline general gating strategies and antibody panels for routine AML analysis.
  • To discuss markers for lineage assignment and differential diagnosis of challenging AML entities.

Main Methods:

  • Review of established flow cytometry protocols and literature.
  • Description of multiparametric immunophenotyping approaches.
  • Analysis of diagnostic immunophenotypic features for AML subclassification.

Main Results:

  • Standardized gating strategies and antibody panels facilitate efficient AML diagnosis.
  • Specific markers aid in lineage assignment and identification of difficult-to-classify AML cases.
  • Flow cytometry principles for minimal residual disease detection are presented.

Conclusions:

  • Flow cytometry immunophenotyping is a cornerstone in AML diagnosis and subclassification.
  • Comprehensive antibody panels and strategic gating improve diagnostic accuracy.
  • The technique is valuable for monitoring treatment response through minimal residual disease detection.